Other OTC Pharmaceuticals - Brunei Darussalam

  • Brunei Darussalam
  • In Brunei Darussalam, the revenue in the Other OTC Pharmaceuticals market reached US$7.60m in 2024.
  • It is projected that the market will experience an annual growth rate of 1.08% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,171.00m in 2024.
  • In terms of per capita figures, each individual in Brunei Darussalam generates revenue of US$16.67 in 2024.
  • Brunei Darussalam's Other OTC Pharmaceuticals market is witnessing a rising demand for traditional herbal remedies among its population.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Brunei Darussalam is experiencing steady growth due to changing customer preferences and local special circumstances.

Customer preferences:
Customers in Brunei Darussalam are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This shift in preference can be attributed to several factors. Firstly, OTC medications are easily accessible and do not require a prescription, allowing consumers to self-diagnose and treat minor ailments without visiting a healthcare professional. Secondly, OTC medications are often more affordable compared to prescription drugs, making them a cost-effective option for consumers. Lastly, the convenience of purchasing OTC medications from pharmacies and retail outlets also contributes to the growing demand.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Brunei Darussalam is the increasing demand for vitamins and dietary supplements. As consumers become more health-conscious, there is a growing interest in preventive healthcare and maintaining overall well-being. This has led to a surge in the consumption of vitamins and dietary supplements, which are readily available in pharmacies and retail outlets. Additionally, there is a rising trend of consumers seeking natural and herbal remedies for various health conditions, further driving the demand for OTC pharmaceuticals in this category.

Local special circumstances:
Brunei Darussalam has a small population with a high per capita income, which contributes to the growth of the Other OTC Pharmaceuticals market. The affluent population is willing to spend on healthcare products and has the purchasing power to afford OTC medications. Moreover, the country has a well-developed healthcare system with a strong emphasis on preventive healthcare. This promotes the use of OTC medications as a means of self-care and maintaining good health.

Underlying macroeconomic factors:
The growth of the Other OTC Pharmaceuticals market in Brunei Darussalam is also influenced by several macroeconomic factors. Firstly, the country's stable economic environment and high disposable income levels contribute to increased consumer spending on healthcare products. Secondly, the government's focus on healthcare and wellness initiatives encourages individuals to take proactive measures in managing their health, leading to higher demand for OTC medications. Lastly, the expanding retail sector and the presence of pharmacies in both urban and rural areas make OTC pharmaceuticals easily accessible to the population.In conclusion, the Other OTC Pharmaceuticals market in Brunei Darussalam is witnessing growth due to changing customer preferences, local special circumstances, and underlying macroeconomic factors. The increasing demand for vitamins and dietary supplements, along with the convenience and affordability of OTC medications, are driving the market's expansion. The country's small but affluent population, stable economic environment, and emphasis on preventive healthcare further contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)